Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

CorMedix (CRMD) EBT: 2010-2024

Historic EBT for CorMedix (CRMD) over the last 15 years, with Dec 2024 value amounting to -$19.3 million.

  • CorMedix's EBT rose 1993.40% to $52.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $107.0 million, marking a year-over-year increase of 351.65%. This contributed to the annual value of -$19.3 million for FY2024, which is 58.30% up from last year.
  • According to the latest figures from FY2024, CorMedix's EBT is -$19.3 million, which was up 58.30% from -$46.3 million recorded in FY2023.
  • In the past 5 years, CorMedix's EBT ranged from a high of -$19.3 million in FY2024 and a low of -$46.3 million during FY2023.
  • In the last 3 years, CorMedix's EBT had a median value of -$30.3 million in 2022 and averaged -$32.0 million.
  • Its EBT has fluctuated over the past 5 years, first slumped by 53.00% in 2023, then surged by 58.30% in 2024.
  • Over the past 5 years, CorMedix's EBT (Yearly) stood at -$27.2 million in 2020, then decreased by 8.32% to -$29.5 million in 2021, then decreased by 2.81% to -$30.3 million in 2022, then tumbled by 53.00% to -$46.3 million in 2023, then surged by 58.30% to -$19.3 million in 2024.